Meeting Held Between H.E. Ambassador Eshete Tilahun and UCB Pharmaceutical Company Representatives.
Ethiopia Encourages Belgian Pharmaceutical Investment.
Today, 5 January 2026, Ambassador Eshete Tilahun met with two senior representatives from UCB, a leading Belgian pharmaceutical company, and discussed investment possibilities in Ethiopian. The meeting focused on exploring opportunities in Ethiopia’s rapidly growing healthcare sector, increasing local and regional demand including through the establishment of Regional Hub.
Ambassador Eshete explained about the investment climate, regulatory landscape, and potential areas of partnership that could be mutually beneficial. He emphasized the government’s commitment to welcoming foreign investors and highlighted ongoing reforms and policies aimed at supporting the pharmaceutical industry. He noted the relative advantage of investing in Ethiopia.
The UCB representatives expressed their keen interest in understanding the Ethiopian market and discussed the available avenues for collaboration.
The meeting concluded with UCB colleagues agreeing to further explore concrete steps that would take them to Addis Ababa to participate in March/April 2026 Business Forums, signaling a promising outlook.
*N.B.* _*UCB is an anchor Belgian bio-pharmaceutical company, develops products and solutions for neurological and immunological diseases worldwide.
